Page last updated: 2024-10-22

albuterol and Benign Monoclonal Gammopathies

albuterol has been researched along with Benign Monoclonal Gammopathies in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vella, FS1
Panella, E1
Masciale, N1
Giannelli, G1
Antonaci, S1

Other Studies

1 other study available for albuterol and Benign Monoclonal Gammopathies

ArticleYear
[Clarkson syndrome: a rare clinical condition characterized by generalized edema associated to monoclonal gammopathy].
    Recenti progressi in medicina, 2005, Volume: 96, Issue:10

    Topics: Adrenergic beta-Agonists; Albuterol; Aminophylline; Angioedema; Anti-Inflammatory Agents; Blood Tran

2005